Affiliation: University of New Mexico
- Impact of therapeutic advances on hypoglycaemia in type 2 diabetesPatrick J Boyle
Department of Internal Medicine, University of New Mexico School of Medicine, Albuquerque, New Mexico 87131, USA
Diabetes Metab Res Rev 24:257-85. 2008..The extent to which this progress can effect improvement over traditional therapies will, however, depend upon patient (and provider) education, motivation and behaviour change...
- What are the effects of peroxisome proliferator-activated receptor agonists on adiponectin, tumor necrosis factor-alpha, and other cytokines in insulin resistance?Patrick J Boyle
University of New Mexico School of Medicine, Albuquerque, New Mexico 87131, USA
Clin Cardiol 27:IV11-6. 2004....
- Thiazolidinediones and clinical diabetes management: new challenges for the fall of 2007Patrick Boyle
Department of Medicine, University of New Mexico Health Sciences Center, Albuquerque, NM 87111, USA
South Med J 100:1063-4. 2007
- Physiological and behavioral aspects of glycemic control and hypoglycemia in diabetesPatrick J Boyle
Department of Internal Medicine, University of New Mexico School of Medicine, Albuquerque, NM 87131, USA
South Med J 100:175-82. 2007..A companion manuscript reviews the clinical symptoms and fundamentals of hypoglycemia prevention, recognition, and management...
- Management of diabetes-related hypoglycemiaPatrick J Boyle
Department of Internal Medicine, University of New Mexico School of Medicine, Albuquerque, NM, USA
South Med J 100:183-94. 2007....
- Diabetes mellitus and macrovascular disease: mechanisms and mediatorsPatrick J Boyle
Department of Medicine, University of New Mexico, Albuquerque, New Mexico 87131 0001, USA
Am J Med 120:S12-7. 2007..Dual PPAR-alpha/gamma agonists, retinoid receptor agonists, and, to a lesser extent, TZDs, also stimulate cholesterol efflux from macrophages in vitro...
- Application of incretin mimetics and dipeptidyl peptidase IV inhibitors in managing type 2 diabetes mellitusPatrick J Boyle
University of New Mexico, Albuquerque, NM 87131 0001, USA
J Am Osteopath Assoc 107:S10-6. 2007..However, the benefits and risks of these agents need to be evaluated more thoroughly, with emphasis on such adverse effects as edema, hypoglycemia, and weight gain...
- Effects of pioglitazone and rosiglitazone on blood lipid levels and glycemic control in patients with type 2 diabetes mellitus: a retrospective review of randomly selected medical recordsPatrick J Boyle
Department of Internal Medicine, School of Medicine, University of New Mexico, Albuquerque, USA
Clin Ther 24:378-96. 2002..The results of clinical trials and observational studies have suggested, however, that there are individual differences in the effects of these drugs on blood lipid levels...
- Extension of type 2 diabetes genome-wide association scan results in the diabetes prevention programAllan F Moore
Center for Human Genetic Research, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA
Diabetes 57:2503-10. 2008....
- Brain oxygen utilization is unchanged by hypoglycemia in normal humans: lactate, alanine, and leucine uptake are not sufficient to offset energy deficitJeffrey M Lubow
Department of Internal Medicine, University of New Mexico, Albuquerque NM 87131 0001, USA
Am J Physiol Endocrinol Metab 290:E149-E153. 2006..min(-1) (P<0.001), and brain alanine uptake trended downward (P<0.08). We conclude that the ATP generated from the physiological increase in BLU during hypoglycemia accounts for no more than 25% of the brain glucose energy deficit...
- Impact of adjunctive thiazolidinedione therapy on blood lipid levels and glycemic control in patients with type 2 diabetesAnne L Peters Harmel
University of Southern California, Keck School of Medicine, Los Angeles, CA, USA
Curr Med Res Opin 20:215-23. 2004..This study was undertaken to assess the effect of pioglitazone hydrochloride and rosiglitazone maleate on blood lipid levels and glycemic control when these drugs are used as adjunctive therapy in type 2 diabetes...
- Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot projectEwan Birney
Nature 447:799-816. 2007..Together, these studies are defining a path for pursuit of a more comprehensive characterization of human genome function...
- BRAIN ENERGY METABOLISM AND HYPOGLYCEMIAPatrick Boyle; Fiscal Year: 2003..Better metabolic control, the key to the prevention of long-term complications of diabetes, will thus become more achievable. ..